7878.TWO Pharmasaga Co. Ltd.
- Market cap
- -
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Is 7878.TWO undervalued?
Graham numberThe Graham number of Pharmasaga Co. Ltd. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Pharmasaga Co. Ltd. fundamental analysis
No fundamental analysis for Pharmasaga Co. Ltd. yet.
Pharmasaga Co. Ltd. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Pharmasaga Co. Ltd.
Pharmasaga Co. Ltd., a drug discovery and development company, focuses on developing anti-diabetic drugs. It develops Pdia4 inhibitors, which includes PS-001 for type 2 diabetes; and PS-002 for type 1 diabetes. The company was founded in 2021 and is based in Taipei, Taiwan.
Full company profileFinancial statements of Pharmasaga Co. Ltd. are not available yet.
Pharmasaga Co. Ltd. dividends
Pharmasaga Co. Ltd. has not paid dividends in the last 1 fiscal years.
Who owns Pharmasaga Co. Ltd.
Ownership data of Pharmasaga Co. Ltd. is not available yet.
Pharmasaga Co. Ltd. company profile
- Company name
- Pharmasaga Co. Ltd.
- Ticker
- 7878.TWO
- Exchange
- Taiwan OTC Exchange
- Sector
- -
- Industry
- -
- Employees
- 15
- Fiscal year end
- December
- Address
- No. 93, Sec. 1, Taipei, Taiwan, 221416
- Phone
- 886 2 2793 8665
- Website
- pharmasaga.com
About Pharmasaga Co. Ltd.
Pharmasaga Co. Ltd., a drug discovery and development company, focuses on developing anti-diabetic drugs. It develops Pdia4 inhibitors, which includes PS-001 for type 2 diabetes; and PS-002 for type 1 diabetes. The company was founded in 2021 and is based in Taipei, Taiwan.
Pharmasaga Co. Ltd. management
2- Ms. Yueh-chen WuChairman & General Manager
- Ms. Wan Jie LinAccounting Supervisor